Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fernández-Avilés, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fernández-Avilés, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Preface

The first 10% of the full text of this article appears below.

As recalled by the recent publication of the European guidelines, the current management of patients with stable angina involves the control of anginal symptoms, the prevention of cardiovascular events—such as acute coronary syndromes, stroke, and cardiovascular death—and the control of cardiovascular risk factors. These measures contribute to preventing or slowing the progression of the disease. Achieving this goal requires prescription of multiple . . . [Full Text of this Article]

Francisco Fernández-Avilés


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?